GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $33.24 $45.00 Friday, 19th Apr 2024 CRBP stock ended at $39.24. This is 7.42% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 11.37% from a day low at $35.79 to a day high of $39.86.
90 days $6.63 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
2021-09-16 $33.30 $34.20 $33.30 $33.90 17 087
2021-09-15 $33.84 $34.50 $33.00 $33.90 28 474
2021-09-14 $34.50 $35.37 $33.30 $33.30 29 977
2021-09-13 $36.20 $36.20 $34.50 $34.50 30 318
2021-09-10 $36.00 $36.03 $35.10 $35.70 15 991
2021-09-09 $35.40 $36.60 $35.40 $36.00 16 974
2021-09-08 $36.30 $36.60 $34.80 $36.30 19 572
2021-09-07 $37.50 $38.70 $36.30 $36.60 26 561
2021-09-03 $39.09 $39.60 $37.20 $37.50 20 303
2021-09-02 $37.80 $39.30 $37.80 $39.30 29 325
2021-09-01 $38.10 $39.30 $37.80 $38.10 18 859
2021-08-31 $35.94 $39.00 $35.94 $38.70 51 924
2021-08-30 $36.60 $36.90 $35.40 $35.70 22 592
2021-08-27 $36.30 $37.80 $36.00 $37.20 17 836
2021-08-26 $37.80 $38.70 $35.70 $36.30 24 360
2021-08-25 $37.80 $38.10 $36.90 $37.50 16 542
2021-08-24 $35.40 $38.40 $35.40 $38.40 36 635
2021-08-23 $33.84 $36.00 $33.60 $36.00 30 536
2021-08-20 $33.60 $35.10 $33.60 $34.20 23 525
2021-08-19 $36.00 $36.60 $33.61 $33.90 26 105
2021-08-18 $36.90 $37.50 $35.70 $36.00 18 208
2021-08-17 $35.10 $38.63 $35.10 $36.90 33 028
2021-08-16 $36.90 $37.50 $35.70 $36.00 36 333
2021-08-13 $37.20 $38.10 $34.50 $37.20 132 243
2021-08-12 $39.60 $40.50 $36.90 $37.80 65 094
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT